Literature DB >> 23430901

Functional Characterization of Five Protoporphyrinogen oxidase Missense Mutations Found in Argentinean Variegate Porphyria Patients.

Manuel Méndez1, Barbara X Granata, María J Morán Jiménez, Victoria E Parera, Alcira Batlle, Rafael Enríquez de Salamanca, María V Rossetti.   

Abstract

A partial deficiency in protoporphyrinogen oxidase (PPOX) produces the acute/cutaneous (or mixed) variegate porphyria (VP), the third most frequent porphyria in Argentina. This autosomal dominant disorder is clinically characterized by skin lesions and/or acute neurovisceral attacks. The precise diagnosis of patients with a symptomatic VP is essential to provide accurate treatment. It is also critical to identify asymptomatic relatives to avoid precipitating factors and prevent acute attacks.Functional consequences of five PPOX missense mutations were evaluated in a prokaryotic expression system. Three mutations were found in families previously reported c.101A>T (p.E34V), c.670T>G (W224G), c.995G>C (G332A) and two were novel findings c.227C>T (p.S76F), c.1265A>G (p.Y422C). All mutations were identified in heterozygotes with reduced PPOX activity and variable clinical expression of the disease, including asymptomatic cases. Prokaryotic expression showed that all five missense mutations decreased the PPOX activity, demonstrating their detrimental effect on enzyme function, and thus, providing evidence for their causative role in VP. These results reinforce the importance of molecular genetic analysis for VP diagnosis and especially the usefulness of prokaryotic expression of missense mutations to assess their deleterious effect on PPOX activity.MM and BXG contributed equally to the publication. RES and MVR share senior authorship.

Entities:  

Year:  2011        PMID: 23430901      PMCID: PMC3509896          DOI: 10.1007/8904_2011_77

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  22 in total

1.  Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect.

Authors:  R Kauppinen; K Timonen; M von und zu Fraunberg; E Laitinen; H Ahola; R Tenhunen; S Taketani; P Mustajoki
Journal:  J Invest Dermatol       Date:  2001-04       Impact factor: 8.551

2.  Structural insight into human variegate porphyria disease.

Authors:  Xiaohong Qin; Ying Tan; Lele Wang; Zhifang Wang; Baifan Wang; Xin Wen; Guangfu Yang; Zhen Xi; Yuequan Shen
Journal:  FASEB J       Date:  2010-11-03       Impact factor: 5.191

3.  Homozygous variegate porphyria.

Authors:  V Korda; J C Deybach; P Martásek; J Zeman; V da Silva; Y Nordmann; H Houśtková; A Rubín; J Holub
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

Review 4.  Homozygous variegate porphyria: an evolving clinical syndrome.

Authors:  R J Hift; P N Meissner; G Todd; P Kirby; D Bilsland; P Collins; J Ferguson; M R Moore
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

5.  Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias.

Authors:  R Enriquez de Salamanca; P Sepulveda; M J Moran; J L Santos; A Fontanellas; A Hernández
Journal:  Clin Exp Dermatol       Date:  1993-03       Impact factor: 3.470

6.  Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard.

Authors:  Richard J Hift; Brandon P Davidson; Cornelis van der Hooft; Doreen M Meissner; Peter N Meissner
Journal:  Clin Chem       Date:  2004-02-19       Impact factor: 8.327

7.  The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts.

Authors:  D A Brenner; J R Bloomer
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

8.  The inherited enzymatic defect in porphyria variegata.

Authors:  J C Deybach; H de Verneuil; Y Nordmann
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria.

Authors:  Rhian R Morgan; Rachel Errington; George H Elder
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 10.  Terminal steps of haem biosynthesis.

Authors:  H A Dailey
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

View more
  1 in total

1.  Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of Argentine patients.

Authors:  María Del Carmen Martinez; Gabriela Nora Cerbino; Bárbara Xoana Granata; Alcira Batlle; Victoria Estela Parera; María Victoria Rossetti
Journal:  Mol Genet Genomic Med       Date:  2021-03-25       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.